Post-acute COVID-19 syndrome.
Post-acute COVID-19 syndrome.
复制标题
DOI:
10.1038/s41591-021-01283-z
复制
发表时间:
2021-04
期刊:
影响因子:
82.9
通讯作者:
Wan EY
中科院分区:
文献类型:
--
作者:
Nalbandian A;Sehgal K;Gupta A;Madhavan MV;McGroder C;Stevens JS;Cook JR;Nordvig AS;Shalev D;Sehrawat TS;Ahluwalia N;Bikdeli B;Dietz D;Der-Nigoghossian C;Liyanage-Don N;Rosner GF;Bernstein EJ;Mohan S;Beckley AA;Seres DS;Choueiri TK;Uriel N;Ausiello JC;Accili D;Freedberg DE;Baldwin M;Schwartz A;Brodie D;Garcia CK;Elkind MSV;Connors JM;Bilezikian JP;Landry DW;Wan EY
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in global healthcare crises and strained health resources. As the population of patients recovering from COVID-19 grows, it is paramount to establish an understanding of the healthcare issues surrounding them. COVID-19 is now recognized as a multi-organ disease with a broad spectrum of manifestations. Similarly to post-acute viral syndromes described in survivors of other virulent coronavirus epidemics, there are increasing reports of persistent and prolonged effects after acute COVID-19. Patient advocacy groups, many members of which identify themselves as long haulers, have helped contribute to the recognition of post-acute COVID-19, a syndrome characterized by persistent symptoms and/or delayed or long-term complications beyond 4 weeks from the onset of symptoms. Here, we provide a comprehensive review of the current literature on post-acute COVID-19, its pathophysiology and its organ-specific sequelae. Finally, we discuss relevant considerations for the multidisciplinary care of COVID-19 survivors and propose a framework for the identification of those at high risk for post-acute COVID-19 and their coordinated management through dedicated COVID-19 clinics.
登录
查看更多内容
影响因子:
158.5
作者:
Ackermann, Maximilian;Verleden, Stijn E.;Jonigk, Danny
通讯作者:
Jonigk, Danny
DOI:
10.1183/16000617.0287-2020
发表时间:
2020-09-30
期刊:
European respiratory review : an official journal of the European Respiratory Society
影响因子:
--
作者:
Bai C;Chotirmall SH;Rello J;Alba GA;Ginns LC;Krishnan JA;Rogers R;Bendstrup E;Burgel PR;Chalmers JD;Chua A;Crothers KA;Duggal A;Kim YW;Laffey JG;Luna CM;Niederman MS;Raghu G;Ramirez JA;Riera J;Roca O;Tamae-Kakazu M;Torres A;Watkins RR;Barrecheguren M;Belliato M;Chami HA;Chen R;Cortes-Puentes GA;Delacruz C;Hayes MM;Heunks LMA;Holets SR;Hough CL;Jagpal S;Jeon K;Johkoh T;Lee MM;Liebler J;McElvaney GN;Moskowitz A;Oeckler RA;Ojanguren I;O'Regan A;Pletz MW;Rhee CK;Schultz MJ;Storti E;Strange C;Thomson CC;Torriani FJ;Wang X;Wuyts W;Xu T;Yang D;Zhang Z;Wilson KC
通讯作者:
Wilson KC
DOI:
10.1007/s42399-020-00369-y
发表时间:
2020-01-01
期刊:
SN comprehensive clinical medicine
影响因子:
--
作者:
Arca, Karissa N;Starling, Amaal J
通讯作者:
Starling, Amaal J
影响因子:
15.8
作者:
Bajaj, Navkaranbir S.;Vaduganathan, Muthiah;Mehra, Mandeep R.
通讯作者:
Mehra, Mandeep R.
影响因子:
10
作者:
Arnold DT;Hamilton FW;Milne A;Morley AJ;Viner J;Attwood M;Noel A;Gunning S;Hatrick J;Hamilton S;Elvers KT;Hyams C;Bibby A;Moran E;Adamali HI;Dodd JW;Maskell NA;Barratt SL
通讯作者:
Barratt SL